8-K - Cardiff Oncology, Inc. | StockGist

Current Report Details

Event Type

Management Change

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers: Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 27

Management Change

8.01

Other Events. On January 27, 2026, the Company issued a press release (the “Press Release”) announcing a positive update from CRDF-004, a randomized, Phase 2 cl

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release of Cardiff Oncology, Inc. dated January 27, 2026. 99.2 Press Release of Cardiff Oncology, In

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2